MENU
+Compare
ASND
Stock ticker: NASDAQ
AS OF
Aug 11, 11:57 AM (EDT)
Price
$194.50
Change
+$3.02 (+1.58%)
Capitalization
11.6B

ASND Ascendis Pharma A/S Forecast, Technical & Fundamental Analysis

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more

Industry: #Biotechnology
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ASND with price predictions
Aug 08, 2025

Momentum Indicator for ASND turns positive, indicating new upward trend

ASND saw its Momentum Indicator move above the 0 level on August 01, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ASND just turned positive on August 01, 2025. Looking at past instances where ASND's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

ASND moved above its 50-day moving average on July 31, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ASND crossed bullishly above the 50-day moving average on August 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ASND advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASND declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ASND broke above its upper Bollinger Band on August 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ASND entered a downward trend on July 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ASND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). ASND's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (19.881) is also within normal values, averaging (286.048).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ASND is expected to report earnings to fall 19.52% to -65 cents per share on November 13

Ascendis Pharma A/S ASND Stock Earnings Reports
Q3'25
Est.
$-0.66
Q2'25
Beat
by $0.45
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.34
Q3'24
Missed
by $0.18
The last earnings report on August 07 showed earnings per share of -81 cents, beating the estimate of -126 cents. With 39.47K shares outstanding, the current market capitalization sits at 11.60B.
A.I. Advisor
published General Information

General Information

a developer of drug candidates

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Tuborg Boulevard 12
Phone
+45 70222244
Employees
879
Web
https://www.ascendispharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IDUB22.780.12
+0.55%
Aptus International Enhanced Yield ETF
BSSX24.970.02
+0.06%
Invesco BulletShares 2033 Muncpl Bd ETF
FLQM54.86N/A
N/A
Franklin US Mid Cap Mltfctr Idx ETF
DFND43.10N/A
N/A
Siren DIVCON Dividend Defender ETF
FFEM29.05-0.02
-0.07%
Fidelity Fundamental Emerging Mkts ETF

ASND and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with NUVL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
+0.60%
NUVL - ASND
38%
Loosely correlated
+2.70%
ZNTL - ASND
37%
Loosely correlated
-0.69%
KYMR - ASND
33%
Loosely correlated
-0.56%
ZYME - ASND
32%
Poorly correlated
-1.15%
BMRN - ASND
31%
Poorly correlated
N/A
More